SERTRALINE HCL MARKET ANALYSIS

Sertraline HCl Market, by Type (25 mg, 50 mg, 100 mg and Others), by Application (Obsessive-Compulsive Disorder, Depression, Panic Disorder, Premenstrual Dysphoric Disorder, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Nov 2022
Code : CMI5355
Pages :156
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Sertraline HCl Market: Key Players

Key players operating in the Sertraline HCl market include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Accord Biopharma, Apotex Inc., Aurobindo Pharma USA, InvaGen, Lupin, Camber Pharmaceuticals, Mylan N.V. (a Part of Viatris Inc.), Sun Pharmaceutical, Wockhardt, Alpic Biotech

Companies covered:

Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Accord Biopharma, Apotex Inc., Aurobindo Pharma USA, InvaGen, Lupin, Camber Pharmaceuticals, Mylan (a part of Viatris Inc.), Sun Pharmaceutical, Wockhardt, Alpic Biotech